We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Recursion Pharmaceuticals
RXRX
$1.68B
| $2.43M | ﹤0.01% |
790,971
-8,107
| -1% | -$31.3K |
|
977
General Dynamics
GD
$104B
| $2.4M | ﹤0.01% |
6,990
-2,683
| -28% | -$952K |
|
978
International Paper
IP
$22.4B
| $2.39M | ﹤0.01% |
66,857
-4,526
| -6% | -$188K |
|
979
PROG Holdings
PRG
$1.83B
| $2.38M | ﹤0.01% |
82,866
+80
| +0.1% | +$2.58K |
|
980
Avantor
AVTR
$9.04B
| $2.37M | ﹤0.01% |
+302,195
| New | +$2.97M |
|
981
Universal Display
OLED
$3.95B
| $2.37M | ﹤0.01% |
25,844
+165
| +0.6% | +$18.2K |
|
982
Fortune Brands Innovations
FBIN
$6.24B
| $2.36M | ﹤0.01% |
60,669
+113
| +0.2% | +$5.88K |
|
983
Triple Flag Precious Metals
TFPM
$6.46B
| $2.36M | ﹤0.01% |
+68,097
| New | +$2.47M |
|
984
NIO
NIO
$11.7B
| $2.35M | ﹤0.01% |
390,436
| – | – |
|
985
Samsara
IOT
$22.6B
| $2.34M | ﹤0.01% |
73,812
-4,253
| -5% | -$130K |
|
986
Mueller Water Products
MWA
$4.13B
| $2.3M | ﹤0.01% |
83,497
+80,352
| +2,555% | +$2.23M |
|
987
J.M. Smucker
SJM
$12.7B
| $2.26M | ﹤0.01% |
23,432
-275,320
| -92% | -$28.8M |
|
988
Hormel Foods
HRL
$13.9B
| $2.26M | ﹤0.01% |
99,728
-11,008
| -10% | -$263K |
|
|
AAT
989
American Assets Trust
AAT
$1.42B
| $2.25M | ﹤0.01% |
122,150
-3,421
| -3% | -$64.1K |
|
990
TTM Technologies
TTMI
$13.6B
| $2.25M | ﹤0.01% |
25,248
+437
| +2% | +$41.6K |
|
991
TAL Education Group
TAL
$6.71B
| $2.2M | ﹤0.01% |
193,152
+62,291
| +48% | +$701K |
|
992
Compañía de Minas Buenaventura
BVN
$8.38B
| $2.19M | ﹤0.01% |
60,876
-489
| -0.8% | -$17.7K |
|
993
Zai Lab
ZLAB
$2.07B
| $2.19M | ﹤0.01% |
116,560
+50,746
| +77% | +$941K |
|
994
Corpay
CPAY
$25.8B
| $2.18M | ﹤0.01% |
7,497
-1,042
| -12% | -$334K |
|
995
dLocal
DLO
$4.47B
| $2.18M | ﹤0.01% |
167,944
-6,717
| -4% | -$87.5K |
|
996
Energizer
ENR
$1.54B
| $2.14M | ﹤0.01% |
130,602
+365
| +0.3% | +$7.38K |
|
|
NYXH
997
Nyxoah
NYXH
$141M
| $2.13M | ﹤0.01% |
754,339
+261,117
| +53% | +$1.1M |
|
998
Edgewell Personal Care
EPC
$1.35B
| $2.13M | ﹤0.01% |
99,776
+555
| +0.6% | +$11.2K |
|
999
EPAM Systems
EPAM
$5.74B
| $2.12M | ﹤0.01% |
15,691
-4
| -0% | -$684 |
|
|
DEA
1000
Easterly Government Properties
DEA
$1.16B
| $2.1M | ﹤0.01% |
97,998
+3,085
| +3% | +$70.5K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.